Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029)

NCT00474617 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Anesthesia, General

Interventions

DRUG: Sugammadex
DRUG: Rocurium

Sponsor

Merck Sharp & Dohme LLC